BioSpace News Archive

Innovative Forensic DNA announces the addition of Andrea Noyes to the firm as Investigative Genetic Genealogist and Co-Managing Director

A new survey of hospital C-suite leaders reveals 35% wish they had chosen a different EMR; more than half say they will seek out HIT solutions beyond the EMR for key needs

Sales Readiness Leader Honored for Enabling Businesses to Quickly and Easily Create Learning Content That Drives Sales Effectiveness and Results

Outset Medical, a leading med tech innovator delivering first-of-its-kind technology into the growing global dialysis market, today announced the appointment of James Hinrichs to its Board of Directors.

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that its Prospera donor-derived cell-free DNA (dd-cfDNA) test has been priced favorably at $2,840.75.

EpicentRx, Inc. announced that the U.S. Food and Drug Administration has cleared the investigational new drug application for AIM-001, an oncolytic adenovirus that is enhanced with a TGF-β trap transgene.

Radius Health, Inc. (Nasdaq: RDUS), today announced that Jesper Høiland, President & CEO and Pepe Carmona, CFO will present a corporate update at the Cowen 40th Annual Healthcare Conference in Boston at 08:40 a.m. ET on Wednesday, March 4, 2020.

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will webcast live presentations at the Cowen and Company 40th Annual Health Care Conference in Boston on Wednesday, March 4, 2020 at 8:20 a.m. PT (11:20 a.m. ET) and at the Barclays Global Healthcare Conference in Miami on Wednesday, March 11, 2020 at 12:20 p.m. PT (3:20 p.m. ET).

Spherix Incorporated announced that it has priced a public offering of an aggregate of 7,142,858 shares of common stock of the Company and warrants to purchase up to 7,142,858 shares of common stock.

Provantis Selected to Improve Study Turnaround Times and Further Increase Data Quality at Pune Facility